Tagbo, Daisy Rose B.
HRN: 24-93-19 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/08/2025
AMPICILLIN 1GM (VIAL)
05/08/2025
05/15/2025
IVT
2gms
Q6
PROM X 5 Hours, Thinly MSAF
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes